Published in Mol Cell Biol on May 22, 2017
The metabolic syndrome. Lancet (2005) 19.47
Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature (2005) 18.41
Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab (2008) 9.74
Mammalian sirtuins: biological insights and disease relevance. Annu Rev Pathol (2010) 8.55
Human fatty liver disease: old questions and new insights. Science (2011) 8.03
Recent progress in the biology and physiology of sirtuins. Nature (2009) 7.73
Inflammatory links between obesity and metabolic disease. J Clin Invest (2011) 6.73
Sirt1 protects against high-fat diet-induced metabolic damage. Proc Natl Acad Sci U S A (2008) 5.21
Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. Cell Metab (2009) 5.02
Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5. Nature (2010) 5.01
Fasting-dependent glucose and lipid metabolic response through hepatic sirtuin 1. Proc Natl Acad Sci U S A (2007) 4.87
Active regulator of SIRT1 cooperates with SIRT1 and facilitates suppression of p53 activity. Mol Cell (2007) 3.67
The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol (2013) 3.51
Evidence for a common mechanism of SIRT1 regulation by allosteric activators. Science (2013) 3.40
Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metab (2011) 3.38
Nucleocytoplasmic shuttling of the NAD+-dependent histone deacetylase SIRT1. J Biol Chem (2006) 3.18
The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. Cell Metab (2012) 3.18
Ten years of NAD-dependent SIR2 family deacetylases: implications for metabolic diseases. Trends Pharmacol Sci (2010) 3.05
The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes. Nature (2014) 2.30
Phosphorylation regulates SIRT1 function. PLoS One (2008) 2.30
FXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease states. Cell Metab (2009) 2.27
SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism. J Biol Chem (2010) 2.20
The ups and downs of SIRT1. Trends Biochem Sci (2008) 1.97
Caloric restriction, SIRT1 and longevity. Trends Endocrinol Metab (2009) 1.89
Targeting sirtuin 1 to improve metabolism: all you need is NAD(+)? Pharmacol Rev (2011) 1.85
Transcriptional regulation of autophagy by an FXR-CREB axis. Nature (2014) 1.57
Sirtuins, aging, and metabolism. Cold Spring Harb Symp Quant Biol (2011) 1.50
Phosphoproteomics Identifies CK2 as a Negative Regulator of Beige Adipocyte Thermogenesis and Energy Expenditure. Cell Metab (2015) 1.49
CK2 is the regulator of SIRT1 substrate-binding affinity, deacetylase activity and cellular response to DNA-damage. PLoS One (2009) 1.43
Sirtuin 1 (SIRT1) protein degradation in response to persistent c-Jun N-terminal kinase 1 (JNK1) activation contributes to hepatic steatosis in obesity. J Biol Chem (2011) 1.33
Small-molecule allosteric activators of sirtuins. Annu Rev Pharmacol Toxicol (2013) 1.31
An ERK/Cdk5 axis controls the diabetogenic actions of PPARγ. Nature (2014) 1.29
A PACS-1, GGA3 and CK2 complex regulates CI-MPR trafficking. EMBO J (2006) 1.15
MicroRNA 34a inhibits beige and brown fat formation in obesity in part by suppressing adipocyte fibroblast growth factor 21 signaling and SIRT1 function. Mol Cell Biol (2014) 1.09
Bile acid signal-induced phosphorylation of small heterodimer partner by protein kinase Cζ is critical for epigenomic regulation of liver metabolic genes. J Biol Chem (2013) 1.06
A dysregulated acetyl/SUMO switch of FXR promotes hepatic inflammation in obesity. EMBO J (2014) 0.92
The multifunctional sorting protein PACS-2 regulates SIRT1-mediated deacetylation of p53 to modulate p21-dependent cell-cycle arrest. Cell Rep (2014) 0.89
Structural basis for allosteric, substrate-dependent stimulation of SIRT1 activity by resveratrol. Genes Dev (2015) 0.89
Sirtuin 1 deacetylase: a key regulator of hepatic lipid metabolism. Vitam Horm (2013) 0.88
Delivery of adenoviral DNA to mouse liver. Methods Mol Biol (2004) 0.87
The N-Terminal Domain of SIRT1 Is a Positive Regulator of Endogenous SIRT1-Dependent Deacetylation and Transcriptional Outputs. Cell Rep (2015) 0.86
SIRT1 phosphorylation by AMP-activated protein kinase regulates p53 acetylation. Am J Cancer Res (2014) 0.84
Critical role of RanBP2-mediated SUMOylation of Small Heterodimer Partner in maintaining bile acid homeostasis. Nat Commun (2016) 0.75
The phosphorylation status of T522 modulates tissue-specific functions of SIRT1 in energy metabolism in mice. EMBO Rep (2017) 0.75